{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-date=2019-06-18&min-answer.questionFirstAnswered.=2022-06-10T13%3A25%3A54.753Z&max-date=2022-05-25", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?min-date=2019-06-18&min-answer.questionFirstAnswered.=2022-06-10T13%3A25%3A54.753Z&max-date=2022-05-25", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-date=2019-06-18&min-answer.questionFirstAnswered.=2022-06-10T13%3A25%3A54.753Z&max-date=2022-05-25&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&min-date=2019-06-18&min-answer.questionFirstAnswered.=2022-06-10T13%3A25%3A54.753Z&max-date=2022-05-25", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-date=2019-06-18&min-answer.questionFirstAnswered.=2022-06-10T13%3A25%3A54.753Z&max-date=2022-05-25", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-date=2019-06-18&min-answer.questionFirstAnswered.=2022-06-10T13%3A25%3A54.753Z&max-date=2022-05-25", "items" : [{"_about" : "http://data.parliament.uk/resources/1465687", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1465687/answer", "answerText" : {"_value" : "<p>The information requested is not held centrally. However, all 29 pathology networks in the National Health Service in England have the capability to undertake the tests required to support the diagnosis of sepsis. Healthcare providers are encouraged to adopt the National Early Warning Score (NEWS2) which supports clinicians to identify and respond to patients at risk of acute deterioration, including those with suspected sepsis.\u202f Since 2019, NEWS2 has been implemented in 100% of ambulance trusts and all except one acute trust in England.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4492", "label" : {"_value" : "Biography information for Maria Caulfield"}
        }
        , "answeringMemberConstituency" : {"_value" : "Lewes"}
        , "answeringMemberPrinted" : {"_value" : "Maria Caulfield"}
        , "dateOfAnswer" : {"_value" : "2022-06-13", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2022-06-13T14:52:13.297Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2022-05-25", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Sepsis: Health Services"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many NHS hospitals follow the sepsis six care pathway approach; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/69", "label" : {"_value" : "Biography information for Sir Oliver Heald"}
      }
      , "tablingMemberConstituency" : {"_value" : "North East Hertfordshire"}
      , "tablingMemberPrinted" : [{"_value" : "Sir Oliver Heald"}
      ], "uin" : "8938"}
    , {"_about" : "http://data.parliament.uk/resources/1465691", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1465691/answer", "answerText" : {"_value" : "<p>The Department continues to work closely with the Department for Transport on the role of hydrogen in decarbonising transport. Government support has included £30m for refuelling infrastructure, which helps support the deployment of 124 hydrogen fuel cell buses.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1526", "label" : {"_value" : "Biography information for Greg Hands"}
        }
        , "answeringMemberConstituency" : {"_value" : "Chelsea and Fulham"}
        , "answeringMemberPrinted" : {"_value" : "Greg Hands"}
        , "dateOfAnswer" : {"_value" : "2022-06-14", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2022-06-14T13:26:36.883Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "201"}
      , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"}
      , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"}
      , "date" : {"_value" : "2022-05-25", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Hydrogen Fuelling Stations"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Business, Energy and Industrial Strategy, whether he has had discussions with the Secretary of State for Transport on ensuring that the provision of hydrogen refuelling infrastructure for transport is considered in the development of new hydrogen production facilities.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4470", "label" : {"_value" : "Biography information for Alan Brown"}
      }
      , "tablingMemberConstituency" : {"_value" : "Kilmarnock and Loudoun"}
      , "tablingMemberPrinted" : [{"_value" : "Alan Brown"}
      ], "uin" : "9040"}
    , {"_about" : "http://data.parliament.uk/resources/1465692", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1465692/answer", "answerText" : {"_value" : "<p>Hydrogen will be fundamental to achieving the full decarbonisation of UK transport. The UK has increased its ambition for up to 10GW of low carbon hydrogen production capacity by 2030. Government analysis, set out in the UK Hydrogen Strategy, shows that transport will be a leading early market for low carbon hydrogen, with up to 6TWh demand in 2030 and up to 45TWh demand in 2035. The Government is exploring all options for low carbon hydrogen use across road freight, buses, trains, maritime and aviation to support the development of a thriving UK hydrogen sector \u2013 including through the recently announced £200m Zero Emission Road Freight Demonstrator programme and £206m UK Shipping Office for Reducing Emissions (UK SHORE).<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1526", "label" : {"_value" : "Biography information for Greg Hands"}
        }
        , "answeringMemberConstituency" : {"_value" : "Chelsea and Fulham"}
        , "answeringMemberPrinted" : {"_value" : "Greg Hands"}
        , "dateOfAnswer" : {"_value" : "2022-06-13", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2022-06-13T06:43:15.143Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "201"}
      , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"}
      , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"}
      , "date" : {"_value" : "2022-05-25", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Transport: Hydrogen"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Business, Energy and Industrial Strategy, what assessment his Department has made of the potential role of hydrogen transport in delivering the increased hydrogen production target set out in the British energy security strategy.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4470", "label" : {"_value" : "Biography information for Alan Brown"}
      }
      , "tablingMemberConstituency" : {"_value" : "Kilmarnock and Loudoun"}
      , "tablingMemberPrinted" : [{"_value" : "Alan Brown"}
      ], "uin" : "9041"}
    , {"_about" : "http://data.parliament.uk/resources/1465693", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1465693/answer", "answerText" : {"_value" : "<p>My rt. hon. Friend the Secretary of State for Business, Energy and Industrial Strategy regularly meets his Cabinet colleagues to discuss measures to support the transformation of the road transport sector to net zero, including investment opportunities in hydrogen vehicles.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1526", "label" : {"_value" : "Biography information for Greg Hands"}
        }
        , "answeringMemberConstituency" : {"_value" : "Chelsea and Fulham"}
        , "answeringMemberPrinted" : {"_value" : "Greg Hands"}
        , "dateOfAnswer" : {"_value" : "2022-06-20", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2022-06-20T07:52:44.99Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "201"}
      , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"}
      , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"}
      , "date" : {"_value" : "2022-05-25", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Motor Vehicles: Hydrogen"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Business, Energy and Industrial Strategy, what discussions he has had with Cabinet colleagues on taking steps to encourage investment in the manufacturing of hydrogen vehicles.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4470", "label" : {"_value" : "Biography information for Alan Brown"}
      }
      , "tablingMemberConstituency" : {"_value" : "Kilmarnock and Loudoun"}
      , "tablingMemberPrinted" : [{"_value" : "Alan Brown"}
      ], "uin" : "9042"}
    , {"_about" : "http://data.parliament.uk/resources/1465696", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1465696/answer", "answerText" : {"_value" : "<p>The Government supports the continuation of the MedTech Funding Mandate (MTFM) policy beyond the next cohort from April 2023 to 2024/2025. The Accelerated Access Collaborative (AAC) and the National Institute for Health and Care Excellence (NICE) monitor the pipeline of technologies receiving the relevant NICE guidance which meet the MTFM criteria. The AAC can modify the policy eligibility criteria to ensure that the policy continues to achieve its objectives. There are no current plans for the Medical Technologies (MedTech) strategy to reassess the role of the MTFM.<\/p><p>The MTFM\u2019s current policy criteria states that technologies must be effective, as demonstrated through positive NICE Medical Technology Guidance or Diagnostic Guidance. Technologies must also be cost saving, with NICE\u2019s modelling demonstrating a net saving within three years and affordable to the National Health Service, with the gross cost impact not exceeding £20 million. While groups and themes may then be identified from the technologies which meet these criteria, they are not a pre-requisite. The selection currently supports only those technologies applicable in secondary care based on the NHS Standard Contract and the National Tariff Payment System. The AAC also consults additional experts on the clinical utility and benefits of potential technologies.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
        }
        , "answeringMemberConstituency" : {"_value" : "Charnwood"}
        , "answeringMemberPrinted" : {"_value" : "Edward Argar"}
        , "dateOfAnswer" : {"_value" : "2022-06-21", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "9032"}
        , {"_value" : "9033"}
        , {"_value" : "9034"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2022-06-21T12:03:28.587Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2022-05-25", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Medical Equipment: Innovation"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what his policy is on the continuation of the MedTech funding mandate beyond the next cohort, which is expected to be authorised for use from April 2023 into 2024-25.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4398", "label" : {"_value" : "Biography information for Chris Green"}
      }
      , "tablingMemberConstituency" : {"_value" : "Bolton West"}
      , "tablingMemberPrinted" : [{"_value" : "Chris Green"}
      ], "uin" : "9031"}
    , {"_about" : "http://data.parliament.uk/resources/1465697", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1465697/answer", "answerText" : {"_value" : "<p>The Government supports the continuation of the MedTech Funding Mandate (MTFM) policy beyond the next cohort from April 2023 to 2024/2025. The Accelerated Access Collaborative (AAC) and the National Institute for Health and Care Excellence (NICE) monitor the pipeline of technologies receiving the relevant NICE guidance which meet the MTFM criteria. The AAC can modify the policy eligibility criteria to ensure that the policy continues to achieve its objectives. There are no current plans for the Medical Technologies (MedTech) strategy to reassess the role of the MTFM.<\/p><p>The MTFM\u2019s current policy criteria states that technologies must be effective, as demonstrated through positive NICE Medical Technology Guidance or Diagnostic Guidance. Technologies must also be cost saving, with NICE\u2019s modelling demonstrating a net saving within three years and affordable to the National Health Service, with the gross cost impact not exceeding £20 million. While groups and themes may then be identified from the technologies which meet these criteria, they are not a pre-requisite. The selection currently supports only those technologies applicable in secondary care based on the NHS Standard Contract and the National Tariff Payment System. The AAC also consults additional experts on the clinical utility and benefits of potential technologies.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
        }
        , "answeringMemberConstituency" : {"_value" : "Charnwood"}
        , "answeringMemberPrinted" : {"_value" : "Edward Argar"}
        , "dateOfAnswer" : {"_value" : "2022-06-21", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "9031"}
        , {"_value" : "9033"}
        , {"_value" : "9034"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2022-06-21T12:03:28.647Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2022-05-25", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Medical Equipment: Innovation"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, whether the MedTech strategy will reassess the role of the MedTech funding mandate.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4398", "label" : {"_value" : "Biography information for Chris Green"}
      }
      , "tablingMemberConstituency" : {"_value" : "Bolton West"}
      , "tablingMemberPrinted" : [{"_value" : "Chris Green"}
      ], "uin" : "9032"}
    , {"_about" : "http://data.parliament.uk/resources/1465698", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1465698/answer", "answerText" : {"_value" : "<p>The Government supports the continuation of the MedTech Funding Mandate (MTFM) policy beyond the next cohort from April 2023 to 2024/2025. The Accelerated Access Collaborative (AAC) and the National Institute for Health and Care Excellence (NICE) monitor the pipeline of technologies receiving the relevant NICE guidance which meet the MTFM criteria. The AAC can modify the policy eligibility criteria to ensure that the policy continues to achieve its objectives. There are no current plans for the Medical Technologies (MedTech) strategy to reassess the role of the MTFM.<\/p><p>The MTFM\u2019s current policy criteria states that technologies must be effective, as demonstrated through positive NICE Medical Technology Guidance or Diagnostic Guidance. Technologies must also be cost saving, with NICE\u2019s modelling demonstrating a net saving within three years and affordable to the National Health Service, with the gross cost impact not exceeding £20 million. While groups and themes may then be identified from the technologies which meet these criteria, they are not a pre-requisite. The selection currently supports only those technologies applicable in secondary care based on the NHS Standard Contract and the National Tariff Payment System. The AAC also consults additional experts on the clinical utility and benefits of potential technologies.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
        }
        , "answeringMemberConstituency" : {"_value" : "Charnwood"}
        , "answeringMemberPrinted" : {"_value" : "Edward Argar"}
        , "dateOfAnswer" : {"_value" : "2022-06-21", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "9031"}
        , {"_value" : "9032"}
        , {"_value" : "9034"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2022-06-21T12:03:28.693Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2022-05-25", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Medical Equipment: Innovation"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what themes or groupings of technologies are being considered for the subsequent MedTech Funding mandate cohorts.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4398", "label" : {"_value" : "Biography information for Chris Green"}
      }
      , "tablingMemberConstituency" : {"_value" : "Bolton West"}
      , "tablingMemberPrinted" : [{"_value" : "Chris Green"}
      ], "uin" : "9033"}
    , {"_about" : "http://data.parliament.uk/resources/1465699", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1465699/answer", "answerText" : {"_value" : "<p>The Government supports the continuation of the MedTech Funding Mandate (MTFM) policy beyond the next cohort from April 2023 to 2024/2025. The Accelerated Access Collaborative (AAC) and the National Institute for Health and Care Excellence (NICE) monitor the pipeline of technologies receiving the relevant NICE guidance which meet the MTFM criteria. The AAC can modify the policy eligibility criteria to ensure that the policy continues to achieve its objectives. There are no current plans for the Medical Technologies (MedTech) strategy to reassess the role of the MTFM.<\/p><p>The MTFM\u2019s current policy criteria states that technologies must be effective, as demonstrated through positive NICE Medical Technology Guidance or Diagnostic Guidance. Technologies must also be cost saving, with NICE\u2019s modelling demonstrating a net saving within three years and affordable to the National Health Service, with the gross cost impact not exceeding £20 million. While groups and themes may then be identified from the technologies which meet these criteria, they are not a pre-requisite. The selection currently supports only those technologies applicable in secondary care based on the NHS Standard Contract and the National Tariff Payment System. The AAC also consults additional experts on the clinical utility and benefits of potential technologies.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
        }
        , "answeringMemberConstituency" : {"_value" : "Charnwood"}
        , "answeringMemberPrinted" : {"_value" : "Edward Argar"}
        , "dateOfAnswer" : {"_value" : "2022-06-21", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "9031"}
        , {"_value" : "9032"}
        , {"_value" : "9033"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2022-06-21T12:03:28.74Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2022-05-25", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Medical Equipment: Innovation"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what criteria his Department uses in informing decision-making around the selected themes as part of the MedTech funding mandate.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4398", "label" : {"_value" : "Biography information for Chris Green"}
      }
      , "tablingMemberConstituency" : {"_value" : "Bolton West"}
      , "tablingMemberPrinted" : [{"_value" : "Chris Green"}
      ], "uin" : "9034"}
    , {"_about" : "http://data.parliament.uk/resources/1465704", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1465704/answer", "answerText" : {"_value" : "<p>The NHS People Plan commits to creating a diverse workforce and reforming staff recruitment and promotion practices to ensure greater inclusivity.<\/p><p>The Workforce Disability Equality Standard (WDES) is a mandated framework of ten measures, including recruitment, which compares the workplace experiences of disabled and non-disabled staff. National Health Service organisations use the data collected to develop action plans and it provides comparative information to demonstrate progress. Following the WDES\u2019s data analysis report in 2021, recommendations include developing opportunities for local unemployed disabled people to gain work experience within NHS organisations and convening inclusive recruitment panels to include disabled staff, particularly for senior roles.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
        }
        , "answeringMemberConstituency" : {"_value" : "Charnwood"}
        , "answeringMemberPrinted" : {"_value" : "Edward Argar"}
        , "dateOfAnswer" : {"_value" : "2022-06-22", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2022-06-22T14:32:28.813Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2022-05-25", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "NHS: Hearing Impairment"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what support is available to deaf people to access employment within the NHS.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4052", "label" : {"_value" : "Biography information for Mark Pawsey"}
      }
      , "tablingMemberConstituency" : {"_value" : "Rugby"}
      , "tablingMemberPrinted" : [{"_value" : "Mark Pawsey"}
      ], "uin" : "8993"}
    , {"_about" : "http://data.parliament.uk/resources/1465713", "AnsweringBody" : [{"_value" : "Foreign, Commonwealth and Development Office"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1465713/answer", "answerText" : {"_value" : "<p>It is the longstanding policy of successive British Governments not to comment on intelligence matters.<\/p><p>The UK has over 200 sanctions designations in place against Iran including in relation to human rights, nuclear proliferation and\u202fterrorism. This includes against the Islamic Revolutionary Guard Corps in its entirety. The UK is committed to working with the international community to ensure Iran abides by international laws and norms and is held to account for its destabilising activity in the region.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4366", "label" : {"_value" : "Biography information for James Cleverly"}
        }
        , "answeringMemberConstituency" : {"_value" : "Braintree"}
        , "answeringMemberPrinted" : {"_value" : "James Cleverly"}
        , "dateOfAnswer" : {"_value" : "2022-06-10", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2022-06-10T13:39:51.973Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "208"}
      , "answeringDeptShortName" : {"_value" : "Foreign, Commonwealth and Development Office"}
      , "answeringDeptSortName" : {"_value" : "Foreign, Commonwealth and Development Office"}
      , "date" : {"_value" : "2022-05-25", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Iran: Espionage and Terrorism"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, if she will make an assessment of the possibility of Iran being engaged in espionage and terrorism in the UK through its embassy and diplomats.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3952", "label" : {"_value" : "Biography information for Mr Toby Perkins"}
      }
      , "tablingMemberConstituency" : {"_value" : "Chesterfield"}
      , "tablingMemberPrinted" : [{"_value" : "Mr Toby Perkins"}
      ], "uin" : "8986"}
    ], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&min-date=2019-06-18&min-answer.questionFirstAnswered.=2022-06-10T13%3A25%3A54.753Z&max-date=2022-05-25", "page" : 0, "startIndex" : 1, "totalResults" : 136, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}